Product Name: Albucel (Intas) 20% — 100 mL Vial
Usage: IV Infusion
Description: Albucel contains Human Albumin 20% w/v for intravenous infusion. It is indicated for the restoration and maintenance of circulating blood volume and for the treatment of hypovolemia and hypoalbuminemia resulting from trauma, surgery, hemorrhage, or during and after kidney dialysis. Albucel helps replace lost plasma proteins and supports oncotic pressure to retain intravascular fluid.
Key Features:
Strength: 20% (20 g per 100 mL)
Pack size: 100 mL vial
Type: Infusion (intravenous)
Albumin source: Human plasma
Pharmacopoeia: IP
Country of origin: India
Prescription status: Prescription only
Indications:
Hypovolemia due to blood loss from trauma or surgery
Hypoalbuminemia (low serum albumin)
Volume expansion during or after dialysis
Other clinical situations where plasma protein replacement is indicated
Dosage and Administration:
Administer intravenously only. Dosage should be individualized based on patient condition, body weight, and clinical response.
Reconstitute or dilute only if indicated by institutional protocol; use aseptic technique.
Monitor vital signs, fluid balance, and serum electrolytes and albumin during and after infusion.
Avoid rapid large-volume infusion in patients at risk for circulatory overload; adjust infusion rate accordingly.
Contraindications and Precautions:
Contraindicated in patients with known hypersensitivity to human albumin or any component of the formulation.
Use with caution in patients with congestive heart failure, severe anemia, or compromised cardiac function due to risk of fluid overload.
Monitor for signs of allergic reaction, including anaphylaxis; discontinue infusion if severe reaction occurs.
Observe standard precautions to prevent transmission of infectious agents; product is derived from human plasma.
Storage:
Store at 2–8°C. Do not freeze.
Protect from light. Use within recommended time after opening per institutional guidelines.
Packaging:
100 mL bottle/vial
Important Safety Information:
For intravenous use only. Prescription product—use under the supervision of a qualified healthcare professional.
Report adverse events to the prescribing clinician or appropriate regulatory body.
For full prescribing information, consult the product monograph or contact the manufacturer.
Please read before placing your order.
Orders may be purchased through our website; however, all medications and peptides are subject to review and approval by a qualified healthcare provider. A Good Faith Exam (GFE) is required every 3 months to maintain eligibility and comply with applicable weight-loss program requirements in your area.
The GFE typically takes approximately 15–20 minutes to complete.
Once completed, the medical review and approval process may take up to 1 full business day in some cases.
Completion of a GFE does not guarantee approval. Final approval is determined by the appropriate healthcare provider based on your medical information and applicable requirements.
A new GFE may be required every 3 months to remain active in the program.
Placing an order does not guarantee that you will be approved for treatment.
If you are not approved by the healthcare provider, your payment will be released/refunded within approximately 3–10 business days. The exact timing may vary depending on your bank or payment provider.
Products are dispensed through appropriately licensed 503A and/or 503B pharmacies, as applicable.
Important: Any statement that products are “FDA approved” should be used only where that statement is legally and factually accurate for the specific medication and formulation being provided. FDA approval of an active ingredient or a commercially available product does not necessarily mean that every compounded preparation containing that ingredient is FDA-approved.
This website notice is intended as general program information and does not replace medical advice, a healthcare provider's evaluation, or applicable federal, state, or local requirements.
Product Name: Albucel (Intas) 20% — 100 mL Vial
Usage: IV Infusion
Description: Albucel contains Human Albumin 20% w/v for intravenous infusion. It is indicated for the restoration and maintenance of circulating blood volume and for the treatment of hypovolemia and hypoalbuminemia resulting from trauma, surgery, hemorrhage, or during and after kidney dialysis. Albucel helps replace lost plasma proteins and supports oncotic pressure to retain intravascular fluid.
Key Features:
Strength: 20% (20 g per 100 mL)
Pack size: 100 mL vial
Type: Infusion (intravenous)
Albumin source: Human plasma
Pharmacopoeia: IP
Country of origin: India
Prescription status: Prescription only
Indications:
Hypovolemia due to blood loss from trauma or surgery
Hypoalbuminemia (low serum albumin)
Volume expansion during or after dialysis
Other clinical situations where plasma protein replacement is indicated
Dosage and Administration:
Administer intravenously only. Dosage should be individualized based on patient condition, body weight, and clinical response.
Reconstitute or dilute only if indicated by institutional protocol; use aseptic technique.
Monitor vital signs, fluid balance, and serum electrolytes and albumin during and after infusion.
Avoid rapid large-volume infusion in patients at risk for circulatory overload; adjust infusion rate accordingly.
Contraindications and Precautions:
Contraindicated in patients with known hypersensitivity to human albumin or any component of the formulation.
Use with caution in patients with congestive heart failure, severe anemia, or compromised cardiac function due to risk of fluid overload.
Monitor for signs of allergic reaction, including anaphylaxis; discontinue infusion if severe reaction occurs.
Observe standard precautions to prevent transmission of infectious agents; product is derived from human plasma.
Storage:
Store at 2–8°C. Do not freeze.
Protect from light. Use within recommended time after opening per institutional guidelines.
Packaging:
100 mL bottle/vial
Important Safety Information:
For intravenous use only. Prescription product—use under the supervision of a qualified healthcare professional.
Report adverse events to the prescribing clinician or appropriate regulatory body.
For full prescribing information, consult the product monograph or contact the manufacturer.
Please read before placing your order.
Orders may be purchased through our website; however, all medications and peptides are subject to review and approval by a qualified healthcare provider. A Good Faith Exam (GFE) is required every 3 months to maintain eligibility and comply with applicable weight-loss program requirements in your area.
The GFE typically takes approximately 15–20 minutes to complete.
Once completed, the medical review and approval process may take up to 1 full business day in some cases.
Completion of a GFE does not guarantee approval. Final approval is determined by the appropriate healthcare provider based on your medical information and applicable requirements.
A new GFE may be required every 3 months to remain active in the program.
Placing an order does not guarantee that you will be approved for treatment.
If you are not approved by the healthcare provider, your payment will be released/refunded within approximately 3–10 business days. The exact timing may vary depending on your bank or payment provider.
Products are dispensed through appropriately licensed 503A and/or 503B pharmacies, as applicable.
Important: Any statement that products are “FDA approved” should be used only where that statement is legally and factually accurate for the specific medication and formulation being provided. FDA approval of an active ingredient or a commercially available product does not necessarily mean that every compounded preparation containing that ingredient is FDA-approved.
This website notice is intended as general program information and does not replace medical advice, a healthcare provider's evaluation, or applicable federal, state, or local requirements.
